HERCESSI

Product NDC
69448-015
11-digit product format
694480015
Labeler code
69448
Product ID
69448-015_893932c5-c667-4ed0-a2bd-a62cc5800b14
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Trastuzumab-strf
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Accord BioPharma Inc.
Application
BLA761346
Marketing category
BLA
Marketing start
2025-01-01
Substance
TRASTUZUMAB-STRF
Active strength
150 mg/7.4mL
Pharmacologic classes
HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
HERCESSI
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TRASTUZUMAB-STRF150 mg/7.4mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
P188ANX8CKInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2700718Internal RxNorm lookup
2700724Internal RxNorm lookup
2700727Internal RxNorm lookup
2700731Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
285d2142-5bfa-401c-9246-7de21c4451afAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
bd11614e-4776-4a92-aaca-2bcbb5f710edProduct name120210115
b914e981-d6dc-4748-bd51-accd6b85b817Product name120190618
9397f6d4-17a1-42b4-beda-fa2c0ea40c8cProduct name120190610
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69448-015-05HERCESSI7.4 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,7.44
69448-015-05HERCESSI1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,14

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
69448-015-05EA - Each69448-015e09e18cf-9529-43e2-9795-cde11f4a7de412024-11-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69448-015HERCESSI (TRASTUZUMAB-STRF) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACCORD BIOPHARMA INC.]4Current NDC, 2 package rows20250323_285d2142-5bfa-401c-9246-7de21c4451af.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HERCESSITRASTUZUMAB-STRFAccord BioPharma Inc.285d2142-5bfa-401c-9246-7de21c4451af2026-10-02Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA761346
ndc (product): 69448-015

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761346Hercessitrastuzumab-strf351(k) BiosimilarRx2026-10-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2700724HERCESSI 150 MG InjectionPSN285d2142-5bfa-401c-9246-7de21c4451af4
2700731HERCESSI 420 MG in 20 ML Injectable SolutionPSN285d2142-5bfa-401c-9246-7de21c4451af4
2700718trastuzumab-strf 150 MG InjectionPSN285d2142-5bfa-401c-9246-7de21c4451af4
2700727trastuzumab-strf 420 MG in 20 ML Injectable SolutionPSN285d2142-5bfa-401c-9246-7de21c4451af4
2700724trastuzumab-strf 150 MG Injection [Hercessi]SBD285d2142-5bfa-401c-9246-7de21c4451af4
2700731trastuzumab-strf 21 MG/ML Injectable Solution [Hercessi]SBD285d2142-5bfa-401c-9246-7de21c4451af4
2700718trastuzumab-strf 150 MG InjectionSCD285d2142-5bfa-401c-9246-7de21c4451af4
2700727trastuzumab-strf 21 MG/ML Injectable SolutionSCD285d2142-5bfa-401c-9246-7de21c4451af4
2700724Hercessi 150 MG InjectionSY285d2142-5bfa-401c-9246-7de21c4451af4
2700731Hercessi 21 MG/ML Injectable SolutionSY285d2142-5bfa-401c-9246-7de21c4451af4
2700731Hercessi 420 MG per 20 ML Injectable SolutionSY285d2142-5bfa-401c-9246-7de21c4451af4
2700727trastuzumab-strf 420 MG per 20 ML Injectable SolutionSY285d2142-5bfa-401c-9246-7de21c4451af4

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
69448-015-05694480015051 VIAL, SINGLE-DOSE in 1 CARTON (69448-015-05) / 7.4 mL in 1 VIAL, SINGLE-DOSE2025-01-01NoNoCurrent